Component: (Network and Table)
Network
00300 - Statement - Consolidated Statement of Cash Flows
(http://www.abbott.com/role/StatementConsolidatedStatementOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000001800 (http://www.sec.gov/CIK)
Consolidated Statement of Cash FlowsPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Consolidated Statement of Cash Flows
 
 
 
Cash Flow From (Used in) Operating Activities:
 
 
 
Net earnings
1,400,000,000  
4,423,000,000  
2,284,000,000  
Adjustments to reconcile earnings to net cash from operating activities -
 
 
 
Depreciation
803,000,000  
871,000,000  
918,000,000  
Amortization of intangible assets
550,000,000  
601,000,000  
630,000,000  
Share-based compensation
310,000,000  
292,000,000  
246,000,000  
Impact of currency devaluation
480,000,000  
  
Investing and financing (gains) losses, net
86,000,000  
(18,000,000) 
69,000,000  
Amortization of bridge financing fees
165,000,000  
  
Net loss on extinguishment of debt
  
18,000,000  
Gain on sale of discontinued operations
(25,000,000) 
(2,840,000,000) 
 
Mylan N.V. equity investment adjustment
947,000,000  
  
Gain on sale of Mylan N.V. shares
 
(207,000,000) 
 
Trade receivables
(177,000,000) 
(171,000,000) 
(195,000,000) 
Inventories
(98,000,000) 
(257,000,000) 
(297,000,000) 
Prepaid expenses and other assets
113,000,000  
57,000,000  
30,000,000  
Trade accounts payable and other liabilities
(652,000,000) 
(742,000,000) 
(225,000,000) 
Income taxes
(699,000,000) 
957,000,000  
197,000,000  
Net Cash From Operating Activities
3,203,000,000  
 
2,966,000,000  
 
3,675,000,000  
 
Cash Flow From (Used in) Investing Activities:
 
 
 
Acquisitions of property and equipment
(1,121,000,000) 
(1,110,000,000) 
(1,077,000,000) 
Acquisitions of businesses and technologies, net of cash acquired
(80,000,000) 
(235,000,000) 
(3,317,000,000) 
Proceeds from business dispositions
25,000,000  
230,000,000  
5,000,000  
Proceeds from the sale of Mylan N.V. shares
 
2,290,000,000  
 
Purchases of investment securities
(2,823,000,000) 
(4,933,000,000) 
(1,507,000,000) 
Proceeds from sales of investment securities
3,709,000,000  
4,112,000,000  
5,624,000,000  
Other
42,000,000  
52,000,000  
70,000,000  
Net Cash From (Used in) Investing Activities
(248,000,000) 
 
406,000,000  
 
(202,000,000) 
 
Cash Flow From (Used in) Financing Activities:
 
 
 
Proceeds from issuance of (repayments of) short-term debt and other
(1,767,000,000) 
(1,281,000,000) 
1,343,000,000  
Proceeds from issuance of long-term debt and debt with maturities over 3 months
14,934,000,000  
2,485,000,000  
 
Repayments of long-term debt and debt with maturities over 3 months
(12,000,000) 
(57,000,000) 
(577,000,000) 
Payment of bridge financing fees
(170,000,000) 
  
Acquisition and contingent consideration payments related to business acquisitions
(25,000,000) 
(17,000,000) 
(400,000,000) 
Purchases of common shares
(522,000,000) 
(2,237,000,000) 
(2,195,000,000) 
Proceeds from stock options exercised, including income tax benefit
248,000,000  
314,000,000  
429,000,000  
Dividends paid
(1,539,000,000) 
(1,443,000,000) 
(1,342,000,000) 
Net Cash From (Used in) Financing Activities
11,147,000,000  
 
(2,236,000,000) 
 
(2,742,000,000) 
 
Effect of exchange rate changes on cash and cash equivalents
(483,000,000) 
(198,000,000) 
(143,000,000) 
Net (Decrease) Increase in Cash and Cash Equivalents
13,619,000,000  
 
938,000,000  
 
588,000,000  
 
Cash and Cash Equivalents, Beginning of Year
5,001,000,000  
4,063,000,000  
3,475,000,000  
Cash and Cash Equivalents, End of Year
18,620,000,000  
 
5,001,000,000  
 
4,063,000,000  
 
Supplemental Cash Flow Information:
 
 
 
Income taxes paid
620,000,000  
631,000,000  
448,000,000  
Interest paid
181,000,000  
166,000,000  
146,000,000